Multidimensional tracking of GPCR signaling via peroxidase-catalyzed proximity labeling
As Medicare coverage expansions in 2025 and 2026 extend GLP-1 drugs to millions of older Americans for the first time, researchers and clinicians are urging a different approach for this age group: more careful baseline assessment, slower dosing, higher protein targets, and proactive monitoring for muscle loss, malnutrition, and bone density decline
Our comprehensive service covers everything from doctor consultations and medication to lab work, unlimited support, and shippingwith no hidden fees
Introduction Alzheimers Disease (AD) is a progressive neurodegenerative disorder that currently lacks effective pharmacotherapies 1
Its ability to improve depressive symptoms without adversely affecting sexual function or body weight, combined with its application in smoking cessation and seasonal affective disorder, underscores its value in a comprehensive mental health treatment plan
He is the founder and director of the Point Institute, an independent research and publishing organization that facilitates the distribution of his many publications